Published in Volume
119, Issue 10 (October 1, 2009)
J Clin Invest. 2009;119(10):2858–2858.
doi:10.1172/JCI41035.
Copyright © 2009, American Society for Clinical
Investigation. Published under the Creative Commons Attribution-No Derivative Works 3.0
License (United States)
Personal Perspective
Linking biomedical research to health care
Elizabeth G. Nabel
National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA. E-mail:
directornhlbi@mail.nih.gov.
First published September 10, 2009
We are in the midst of a vitally important discussion on health care. This
debate has provided insights into who we are as Americans and what we value. We clearly
value our health and our health care. We believe that health and access to quality health
care are a human right. As physicians, many of us have worked in impoverished areas in this
country and abroad, and we’ve seen that the poor can often be deprived of such
rights. We have had the privilege of providing medical care to people who otherwise would
not be able to get it. The number of health care professionals eager to serve is
impressive, and so is the amount that can be accomplished. And so, our efforts as
physicians to advocate for health as a human right, to reduce Americans’
vulnerability, and to care for those in need must be heard.
Another insight is obvious to those who engage in biomedical research, but the message is
likely underappreciated by the American public. Biomedical research provides the basis for
progress in health and health care. Basic discoveries, translation to clinical medicine,
and implementation into medical practice have been the story line of medical advances for
decades. And the vast majority of basic discoveries have been funded by the National
Institutes of Health through taxpayers’ investment in biomedical research. So
why isn’t NIH-funded research mentioned more in our health care discussion? We
know the likely causes: it is difficult to draw a straight line between NIH-funded research
and improvements in health care; many basic science advances take decades before being
fully developed into therapeutics and fully implemented into medical practice; and
reporting of medical advances rarely includes attribution to NIH funding. But this is a
very special time for our biomedical community. We are the recipients of approximately $10
billion of American Recovery and Reinvestment Act (ARRA) funds, and we can use the health
care discussion as an opportunity to articulate (a) our gratitude for the enormous
investment made by the American public in the biomedical research enterprise; (b) how
ARRA-supported research will accelerate medical progress by helping to deliver new
treatments and prevention strategies to reduce disease; (c) the synergy among university,
academic health centers, and NIH support for training the next generation of
physician-scientists and biomedical leaders; and (d) the current and future scientific
opportunities that will empower the biomedical research community.
Knowledge gained from important fields of NIH-funded research will contribute significantly
to our progress in achieving affordable and high-quality health care for all Americans.
Comparative effectiveness research, for example, involves conducting and synthesizing
research comparing the benefits and harms of different interventions and strategies to
prevent, diagnose, treat, and monitor health conditions in real-world settings. The goal of
this research is to improve health outcomes by developing and disseminating evidence-based
information to patients, clinicians, and other decision makers about which interventions
are most effective for which patients in specific circumstances. The NIH has a long and
rich tradition of comparative effectiveness research and is well positioned to play a major
leadership role in continuing to fund this research. We understand that patient-centered
health research is vital to effective health care, and the results of comparative
effectiveness research can direct the right treatment to the right person in the right
setting at the right time. Other areas in which NIH-funded research will inform the health
care discussion include health economics, health systems research, health disparities, and
personalized medicine, to name a few.
As physicians, we carry within us a belief that health and access to quality health care
are a human right; that when the health system does not serve many of our fellow Americans
well, we must change it. Biomedical research offers hope to improve vaccines, therapeutics,
devices, and health system approaches that will bring health and security to our fellow
Americans. Our health care discussion is not solely about our nation’s health;
it is also a statement about what we value.